SARS-Cov-2 transmission to humans most likely via intermediary species through convoluted path: WHO


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ SARS-Cov-2 transmission to humans most likely via intermediary species through convoluted path: WHO
WHO team report from Wuhan

The WHO team of experts investigating the origin of novel coronavirus SARS-CoV-2 in Wuhan said that the virus most probably jumped to humans via an intermediary species.

Dr Peter Ben Embarek, head of the WHO-led team told their assessment to the press on Tuesday about their initial findings which suggest that the introduction to humans through an intermediary host species is the most likely pathway and one way that will require more studies and more specific targeted research.

As the team was wrapping up a highly watched, nearly a month-long visit to Wuhan, he said, its investigation had uncovered new information but had not dramatically changed the picture of the outbreak but it did 'add details to that story.' 

He added that work to identify the origins of the coronavirus points to a natural reservoir in bats, but it is unlikely that they were in Wuhan, the central Chinese city where the outbreak was discovered in late 2019. The possible path from whatever original animal species all the way through to the Huanan market could have taken a very long and convoluted path.
 
The Chinese and foreign experts considered several options for how the disease first ended up in humans, leading to a pandemic that has now killed more than 2.3 million people worldwide. The WHO team probed four hypotheses around the transmission of Coronavirus to the human population and concluded that the most likely scenario of the introduction of coronavirus to humans is through an intermediary host species. Other possibilities being direct transmission from animal to humans, transmission from frozen food to humans and the possibility of a leakage from the lab. The joint Chinese-WHO team dismissed the possibility of the laboratory-related incident saying that findings suggest that the laboratory hypothesis is extremely unlikely to explain the introduction of the virus to the human population so that will not be recommended for future studies. China had already strongly rejected that possibility and has promoted other theories.
 
Other hypotheses need future studies. Embarek, the WHO’s food safety scientist said that viruses can survive in frozen environments but added that the possibility of cold chain transmission of coronavirus warrants further investigation. China has often pushed the hypothesis of cold chain transmission and repeatedly announced findings of coronavirus traces on imported food packaging. The WHO expert said that the hypothesis of direct transmission from an animal reservoir to a human, also known as 'direct zoonotic spillover', is a possible pathway and recommended it for future studies.
 
During the initial days of Covid-19 outbreak, preliminary studies had suggested that the bats could be the source since the coronavirus present in bats has a genome that is 96 per cent identical to SARS-CoV-2. An intermediary host species has been considered the most likely pathway for such viruses because the bat coronavirus cannot bind to receptors in human lung cells. However, the animal source of the pandemic could not be identified. The WHO team said that a lot of targeted studies are required for origin tracing as was the case with other outbreaks like Ebola, SARS etc. which are still not clear. The team found no evidence that the disease was spreading widely any earlier than the initial outbreak in the second half of December 2019 in Wuhan. Now, the team will try to link the data points collected during this visit which they consider as the initial step. Final report of the WHO team will be awaited which may take some time.

Earlier, members of the WHO team tried to manage the expectations for the mission, saying it would probably take years to fully understand the origins of Covid-19. They also said that they got good cooperation from the Chinese side. The visit by the WHO team took months of negotiation before getting approval from China. While China has contained some localized waves of infection since getting the outbreak under control last year, life in Wuhan has largely returned to normal.

Tags : #Coronavirus #Wuhan #China #WHO #WHOprobeChina #DrPeterBenEmbarek #EbolaSars

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026